CRELD1
Basic information
Region (hg38): 3:9933793-9945413
Previous symbols: [ "AVSD2" ]
Links
Phenotypes
GenCC
Source:
- atrioventricular septal defect, susceptibility to, 2 (Moderate), mode of inheritance: AD
- atrioventricular septal defect, susceptibility to, 2 (Strong), mode of inheritance: AD
- atrioventricular septal defect, susceptibility to, 2 (Limited), mode of inheritance: AD
- congenital heart disease (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Atrioventricular septal defect, partial, with or without heterotaxy; Jeffries-Lakhani neurodevelopmental syndrome | AD/AR | Allergy/Immunology/Infectious; Cardiovascular | Atrioventricular septal defect, partial, with or without heterotaxy can involve congenital cardiac anomalies, and awareness may allow early management; Jeffries-Lakhani neurodevelopmental syndrome can involve recurrent infections and cardiovascular anomalies, including cardiac arrhythmias requiring defribillator placement, as well as cardiac malformations in some individuals, and awareness can allow early and aggressive treatment of infections as well as identification and management of cardiovascular manifestations | Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Gastrointestinal; Neurologic; Ophthalmologic | 12632326; 15857420; 21080147; 22740159; 3794718 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRELD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 22 | 29 | ||||
missense | 55 | 65 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 9 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 5 | 2 | 9 | ||
non coding | 14 | 24 | ||||
Total | 0 | 3 | 70 | 36 | 24 |
Variants in CRELD1
This is a list of pathogenic ClinVar variants found in the CRELD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-9933888-C-T | Benign (May 11, 2021) | |||
3-9934176-T-C | Benign (May 17, 2021) | |||
3-9934334-G-T | Benign (Nov 12, 2018) | |||
3-9934446-C-T | CRELD1-related disorder | Uncertain significance (May 29, 2024) | ||
3-9934471-A-G | Likely benign (Dec 03, 2018) | |||
3-9934475-A-G | Atrioventricular septal defect, susceptibility to, 2 | Benign (Feb 01, 2024) | ||
3-9934475-A-A | not specified • Atrioventricular septal defect, susceptibility to, 2 | Benign (Jan 14, 2024) | ||
3-9934485-G-A | Inborn genetic diseases | Uncertain significance (Dec 20, 2021) | ||
3-9934504-C-T | Atrioventricular septal defect, susceptibility to, 2 | Likely benign (Jul 25, 2022) | ||
3-9934518-T-G | Atrioventricular septal defect, susceptibility to, 2 | Uncertain significance (Jun 13, 2022) | ||
3-9934531-C-T | Atrioventricular septal defect, susceptibility to, 2 | Benign (Dec 20, 2023) | ||
3-9934533-C-T | Atrioventricular septal defect, susceptibility to, 2 • Inborn genetic diseases | Uncertain significance (Apr 29, 2024) | ||
3-9934553-C-T | Inborn genetic diseases | Uncertain significance (Dec 12, 2023) | ||
3-9934557-C-G | Inborn genetic diseases | Uncertain significance (Mar 14, 2023) | ||
3-9934557-C-T | Inborn genetic diseases | Uncertain significance (Oct 29, 2021) | ||
3-9934574-T-G | Uncertain significance (Dec 06, 2019) | |||
3-9934617-G-A | Uncertain significance (Dec 14, 2023) | |||
3-9934623-C-T | Atrioventricular septal defect, susceptibility to, 2 | Likely benign (Dec 21, 2023) | ||
3-9934816-A-G | Atrioventricular septal defect, susceptibility to, 2 | Likely benign (Apr 11, 2021) | ||
3-9934875-A-G | Atrioventricular septal defect, susceptibility to, 2 | Uncertain significance (Jan 08, 2023) | ||
3-9934883-T-C | Congenital heart defects, multiple types, 4 | Pathogenic (-) | ||
3-9934892-G-C | Uncertain significance (Jan 11, 2022) | |||
3-9934894-G-T | Atrioventricular septal defect, susceptibility to, 2 | Uncertain significance (Jun 19, 2023) | ||
3-9934911-AAGAC-A | Likely pathogenic (Nov 30, 2018) | |||
3-9934927-T-G | Atrioventricular septal defect, susceptibility to, 2 | Benign (Aug 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CRELD1 | protein_coding | protein_coding | ENST00000326434 | 11 | 11592 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.34e-11 | 0.539 | 125590 | 0 | 158 | 125748 | 0.000628 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.175 | 235 | 243 | 0.968 | 0.0000143 | 2740 |
Missense in Polyphen | 84 | 92.424 | 0.90885 | 1018 | ||
Synonymous | -1.48 | 111 | 92.8 | 1.20 | 0.00000573 | 798 |
Loss of Function | 1.36 | 21 | 28.9 | 0.727 | 0.00000182 | 298 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00125 | 0.00125 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000995 | 0.000994 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000197 | 0.000196 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Disease
- DISEASE: Atrioventricular septal defect 2 (AVSD2) [MIM:606217]: A congenital heart malformation characterized by a common atrioventricular junction coexisting with deficient atrioventricular septation. The complete form involves underdevelopment of the lower part of the atrial septum and the upper part of the ventricular septum; the valve itself is also shared. A less severe form, known as ostium primum atrial septal defect, is characterized by separate atrioventricular valvar orifices despite a common junction. {ECO:0000269|PubMed:12632326, ECO:0000269|PubMed:15857420}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0922
Intolerance Scores
- loftool
- 0.424
- rvis_EVS
- 0.38
- rvis_percentile_EVS
- 75.51
Haploinsufficiency Scores
- pHI
- 0.0920
- hipred
- N
- hipred_score
- 0.169
- ghis
- 0.468
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.402
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Creld1
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- endocardial cushion development;cardiac septum development
- Cellular component
- integral component of membrane;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent;calcium ion binding